EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route

Alok Kumar Mahor, Prem Prakash Singh, Rishikesh Gupta, Peeyush Bhardwaj, Priyanka Rathore, Ankita Kishore, Rohit Goyal, Neeraj Sharma, Jyoti Verma, Jessica M. Rosenholm, Kuldeep K. Bansal

Journal of Nanotechnology · 06.11.2023 · 2023 · 1-35

DOI: 10.1155/2023/4687959 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nanotechnology, erschienen am 06.11.2023. Verfasst von Alok Kumar Mahor und 10 weiteren Autor:innen. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Business Finland, FinELib.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug delivery via the oral route has always been challenging for poorly soluble drugs. Acid-induced hydrolysis, enzymatic degradation, and poor mucosal absorbency remain the primary hiccups for effective oral delivery of medications. With the advent of nanotechnology, nanostructured lipid carriers (NLCs) have emerged as a promising delivery carrier that can circumvent gastrointestinal tract (GIT) barriers hindering the solubility and bioavailability of such drugs. These NLCs can efficiently transport drug moieties across intestinal membranes shielding medications from intestinal pH and enzymatic degradation. Because they are composed of lipidic materials, they can be easily absorbed or taken up by various pathways such as transcellular absorption, paracellular transport, and M-cell uptake. Such mechanisms not only improve the absorption and solubility of drugs but also augment bioavailability and residence time and may bypass first-pass metabolism. This review explores the diverse applications of nanostructured lipid carriers (NLCs) in oral drug delivery for various medical conditions, shedding light on their current regulatory status, including FDA-approved options and those in pre/clinical stages. The review also features patented NLC formulations. It provides valuable insights into how NLCs can be harnessed for effective oral drug delivery and outlines recent advancements in optimizing their performance to tackle gastrointestinal barriers, thus opening new possibilities for NLCs in future pharmaceutical applications.

Förderung

  • Business Finland
  • FinELib

Zitieren

APA

Mahor, A. K., Singh, P. P., Gupta, R., Bhardwaj, P., Rathore, P., Kishore, A., Goyal, R., Sharma, N., Verma, J., Rosenholm, J. M., & Bansal, K. K. (2023). Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route. Journal of Nanotechnology, 2023, 1-35. https://doi.org/10.1155/2023/4687959

Vancouver

Mahor AK, Singh PP, Gupta R, Bhardwaj P, Rathore P, Kishore A, et al. Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route. Journal of Nanotechnology. 2023;2023:1-35. doi:10.1155/2023/4687959

BibTeX
@article{Mahor2023,
  author = {Mahor, Alok Kumar and Singh, Prem Prakash and Gupta, Rishikesh and Bhardwaj, Peeyush and Rathore, Priyanka and Kishore, Ankita and Goyal, Rohit and Sharma, Neeraj and Verma, Jyoti and Rosenholm, Jessica M. and Bansal, Kuldeep K.},
  title = {Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route},
  journal = {Journal of Nanotechnology},
  year = {2023},
  volume = {2023},
  pages = {1--35},
  doi = {10.1155/2023/4687959}
}
Kostenlos starten →